查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球伤口护理市场 - 2023-2030
市场调查报告书
商品编码
1347969

全球伤口护理市场 - 2023-2030

Global Wound Care Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

全球伤口护理市场在 2022 年达到 185 亿美元，预计到 2030 年将达到 254 亿美元，2023-2030 年预测期间复合年增长率为 4.5%。

伤口护理主要集中于治疗压疮、糖尿病足溃疡、皮肤撕裂、手术伤口和烧伤以及其他一般伤口。全球伤口护理市场正在受到产品推出和批准数量增加的推动。此外，糖尿病足溃疡和压疮等慢性伤口的患病率不断增加，交通事故和自然灾害等造成的外伤病例也不断增加。

预计北美地区将在市场份额中占据重要地位。糖尿病足溃疡领域占有重要的市场份额。用于治疗疾病的产品的批准和疾病患病率的增加使该细分市场处于重要地位。

动力学

产品发布数量的增加预计将推动市场增长

预计产品发布数量的增加将推动市场增长。例如，2023年6月13日，赢创公司JeNaCell推出了伤口敷料Epicite Balance，用于腿部静脉性溃疡、腿部动脉性溃疡、糖尿病足溃疡、压疮和软组织病变等慢性伤口。 Epicite 天平有三种不同的尺寸，将通过 Coopmed ApS 公司分发给医院和家庭护理中心。

此外，2022 年 10 月 10 日，总部位于班加罗尔的 Healthium Medtech 推出了新的伤口敷料组合 Theruptor Novo，用于治疗糖尿病足溃疡和腿部溃疡等慢性伤口。随着 Theruptor Novo 的推出，Healthium 增强了其在先进伤口敷料领域现有的专利产品组合。因此，产品发布数量的增加预计将推动市场增长。

主要公司的战略预计将推动市场增长

收购、合作和伙伴关係等策略加强了市场增长。这些公司的战略预计将推动市场增长。例如，2023 年 5 月 10 日，LifeNet Health 收购了 Bioventus Inc. 伤口护理部门，扩大了其伤口护理解决方案组合，添加了 TheraSkin 等革命性产品。这一倡议巩固了 LifeNet Health 作为再生医学领域全球领导者的地位，提供更高水平的伤口护理。

这些公司的收购预计也将加速市场增长。例如，2023 年 7 月 7 日，康乐保达成协议，以高达 13 亿美元（约 89 亿丹麦克朗）收购冰岛伤口护理公司 Kerecis，原因是该公司在美国生物製品行业的增长潜力所吸引。因此，公司战略预计将推动市场增长。

伤口护理产品的高成本将限制市场增长

伤口护理产品成本的上涨是市场扩张的主要障碍。这是由于原材料和劳动力价格上涨，导致敷料、绷带、消毒剂和其他产品等伤口护理用品的成本增加。许多人买不起高成本、先进的伤口护理产品，这可能会阻碍市场的增长。例如，ActiGraft 4 週内的产品成本在 1,710 美元到 3,780 美元之间。

目录

第 1 章：方法和范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章：定义和概述

第 3 章：执行摘要

  • 按产品分类的片段
  • 按伤口类型分類的片段
  • 最终用户的片段
  • 按地区分類的片段

第 4 章：动力学

  • 影响因素
    • 司机
      • 增加产品发布数量
      • 重点企业战略
    • 限制
      • 伤口护理产品成本高
    • 机会
    • 影响分析

第 5 章：行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 俄乌战争影响分析
  • DMI 意见

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商战略倡议
  • 结论

第 7 章：副产品

  • 高级伤口敷料
  • 手术伤口敷料
  • 传统伤口敷料
  • 薄膜敷料
  • 海藻酸盐敷料
  • 水凝胶敷料
  • 其他的

第 8 章：按伤口类型

  • 糖尿病足溃疡
  • 压疮
  • 手术和外伤
  • 腿部静脉溃疡
  • 伯恩斯
  • 其他伤口

第 9 章：最终用户

  • 医院
  • 专科诊所
  • 家庭护理设置
  • 其他的

第 10 章：按地区

  • 北美
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第 11 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 12 章：公司简介

  • Smith & Nephew PLC.
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Molnlycke Health Care Ab
  • Baxter International Inc.
  • Acelity LP Inc.
  • Integra Lifesciences Holding Corporation
  • Coloplast A/S
  • Ethicon Inc
  • 3M
  • Medline Industries, LP.
  • Convatec Group.

第 13 章：附录

简介目录
Product Code: MD2203

Overview

Global Wound Care Market reached US$ 18.5 billion in 2022 and is expected to reach US$ 25.4 billion by 2030, growing with a CAGR of 4.5% during the forecast period 2023-2030.

Wound care has been focussed mainly on treating pressure ulcers, diabetic foot ulcers, skin tears, surgical wounds and burns, and other general wounds. The global wound care market is being driven by the increased number of launches of the products and their approvals. Additionally, there is an increased prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, as well as the rising occurrences of trauma cases, such as those caused by vehicle accidents and natural disasters.

The North America region is expected to hold a significant position in the market share. The diabetic foot ulcers segment holds a significant market share. The approvals of the products in managing the condition and the increase in the prevalence of the disease are holding the segment in a significant position.

Dynamics

Increased Number of Product Launches is Expected to Drive the Market Growth

An increased number of product launches are expected to drive the market growth. For instance, on June 13, 2023, Evonik company JeNaCell launched a wound dressing Epicite balance for chronic wounds, such as venous leg ulcers, arterial leg ulcers, diabetic foot ulcers, pressure ulcers, and soft tissue lesions. Epicite balance comes in three different sizes and will be distributed through the company Coopmed ApS to hospitals and homecare centers.

Additionally, on 10 October 2022, Bengaluru-based Healthium Medtech launched a new wound dressing portfolio Theruptor Novo for the management of chronic wounds like diabetic foot ulcers and leg ulcers. With the launch of Theruptor Novo, Healthium strengthens its existing portfolio of patented products in the advanced wound dressing segment. Thus, an increase in the number of product launches is expected to drive the market growth.

Strategies by the Key Companies are Expected to Drive Market Growth

Strategies such as acquisitions, collaborations, and partnerships strengthen the market growth. The strategies by the companies are expected to drive the market growth. For instance, on May 10, 2023, LifeNet Health expanded its portfolio of wound care solutions, adding revolutionary products such as TheraSkin, with the acquisition of the Bioventus Inc. wound care division. This step strengthens LifeNet Health's position as a global leader in regenerative medicine, offering next-level wound care.

Acquisition of the companies is also expected to accelerate the market growth. For instance, on July 7, 2023, Coloplast came to an agreement to acquire Kerecis, an Icelandic wound care company, for up to $1.3 billion (around DKK 8.9 billion), attracted by the company's assumed growth potential in the United States biologics sector. Thus, the company strategies are expected to drive the market growth.

High Cost of Wound Care Products will Restrict the Market Growth

The rising cost of wound care products is a major hindrance to the market's expansion. This is due to increased raw material and labor prices, which are increasing the cost of wound care items such as dressings, bandages, antiseptics, and other products. High-cost, advanced wound care products cannot be afforded by many individuals, which can hamper the market growth. For instance, ActiGraft had a product cost ranging from $1,710 to $3,780 over 4 weeks.

Segment Analysis

The global wound care market is segmented based on product, wound type, end-user, and region.

Diabetic Foot Ulcers Segment Holds a Significant Position in the Market Share

An increase in the prevalence of diabetic foot ulcers is expected to hold the segment growth. For instance, according to NIH, approximately 18.6 million people worldwide are affected by diabetic foot ulcers each year, including 1.6 million people in the United States. These ulcers precede 80% of lower extremity amputations among people diagnosed with diabetes and are associated with an increased risk of death.

Additionally, diabetic foot ulcers were found in 4.54% of patients newly diagnosed with type 2 diabetes mellitus in India, and the prevalence of DFS at the primary care level in Germany is 2.9%. Thus, these factors are expected to hold the segment growth.

Geographical Penetration

North America Region Holds the Largest Market Share in the Global Wound Care Market

North America is expected to hold a dominant share of the market. The increase in the number of launches is expected to hold the region in a significant position. The presence of major players and an increased number of product launches are expected to drive the region's market share. For instance, on 3 January 2023, Convatec announced the US launch of ConvaFoam, a family of advanced foam dressings designed to address the needs of healthcare providers and their patients. ConvaFoam can be used on a spectrum of wound types at any stage of the wound journey, making it the simple dressing choice for wound management and skin protection.

Additionally, on July 18, 2023, RedDress Medical launched ActiGraft PRO with G-Code reimbursement status for the US wound Care market. Thus, the high number of approvals and launches of the products is holding the region in a significant position.

Competitive Landscape

The global wound care market is fragmented, with the presence of many local and international players. Smith & Nephew PLC., Molnlycke Health Care Ab, Baxter International Inc., Acelity L.P. Inc., Integra Lifesciences, Holding Corporation, Coloplast A/S, Ethicon Inc, 3 M, Medline Industries, LP., and Convatec Group. are the leading Companies with a significant market share.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global wound care market. COVID-19 pandemic caused disruption in the manufacturing of wound care products. The availability of wound care products has been reduced due to the outbreak of the pandemic.

As the coronavirus rapidly spread, medical attention shifted to treating COVID-affected patients while protecting others from infection. Patients became apprehensive about seeking wound care due to shelter-in-place orders and concerns about contracting the coronavirus. Thus, COVID-19 has impacted the market growth negatively.

Key Developments

  • On MARCH 3, 2023, Bactiguard released a broad range of infection prevention solutions, from a unique coating technology to a portfolio of coated medical devices. The portfolio also includes biocompatible and effective wound care products, which are now launched in the UK and Ireland.

By Product

  • Advanced Wound Dressings
  • Surgical Wound Dressings
  • Traditional Wound Dressings
  • Film Dressings
  • Alginate Dressings
  • Hydrogel Dressings
  • Others

By Wound Type

  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Surgical & Traumatic Wounds
  • Venous Leg Ulcers
  • Burns
  • Other Wounds

By End-User

  • Hospitals
  • Specialty Clinics
  • Home Care Settings
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Why Purchase the Report?

  • To visualize the global wound care market segmentation based on product, wound type, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of wound care market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global wound care market report would provide approximately 61 tables, 58 figures, and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Wound Type
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increased number of product launches
      • 4.1.1.2. Strategies by the key companies
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of wound care products
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Advanced Wound Dressings *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Surgical Wound Dressings
  • 7.4. Traditional Wound Dressings
  • 7.5. Film Dressings
  • 7.6. Alginate Dressings
  • 7.7. Hydrogel Dressings
  • 7.8. Others

8. By Wound Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 8.1.2. Market Attractiveness Index, By Wound Type
  • 8.2. Diabetic Foot Ulcers *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Pressure Ulcers
  • 8.4. Surgical & Traumatic Wounds
  • 8.5. Venous Leg Ulcers
  • 8.6. Burns
  • 8.7. Other Wounds

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Home Care Settings
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Smith & Nephew PLC. *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Molnlycke Health Care Ab
  • 12.3. Baxter International Inc.
  • 12.4. Acelity L.P. Inc.
  • 12.5. Integra Lifesciences Holding Corporation
  • 12.6. Coloplast A/S
  • 12.7. Ethicon Inc
  • 12.8. 3M
  • 12.9. Medline Industries, LP.
  • 12.10. Convatec Group.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us